Article info

Download PDFPDF
Bimatoprost 0.03% preservative-free ophthalmic solution versus bimatoprost 0.03% ophthalmic solution (Lumigan) for glaucoma or ocular hypertension: a 12-week, randomised, double-masked trial

Authors

  1. Correspondence to Dr Douglas G Day, Coastal Research Associates, 11205 Alpharetta Highway, Suite J-3, Roswell, GA 30076, USA; dougday{at}bellsouth.net
View Full Text

Citation

Day DG, Walters TR, Schwartz GF, et al
Bimatoprost 0.03% preservative-free ophthalmic solution versus bimatoprost 0.03% ophthalmic solution (Lumigan) for glaucoma or ocular hypertension: a 12-week, randomised, double-masked trial

Publication history

  • Received December 26, 2012
  • Revised March 29, 2013
  • Accepted April 27, 2013
  • First published June 6, 2013.
Online issue publication 
July 10, 2013

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

    Files in this Data Supplement:

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.